Pharmaceutical traceability stumbles ahead

We’ve been covering the topic of pharmaceutical traceability and compliance with the Drug Supply Chain Security Act (DSCSA) closely for years, in part because its implications are so fundamental to how drugs will be distributed and dispensed nationally and globally […]

Read More

The sales rep study I’d like to see

We’re not sure what to make of a just-released JAMA study* by two professors of, respectively, business management, and economics and psychology, after a highly detailed study of the prescribing practices at academic medical centers. The goal was to compare […]

Read More

PBM hostility to independent pharmacies and small wholesalers

Secondary wholesalers (aka “independent” wholesalers) play a 
unique part of the pharmaceutical distribution business. Although, little loved by the largest manufacturers and wholesalers, their existence is entirely legal—and valuable to the overall healthcare system. These wholesalers function by arbitraging pricing […]

Read More

Hey, what’s this supply chain stuff?

Call it an example of unintended consequences: When Pharmaceutical Commerce began publication in 2005, supply chain issues were relatively unrecognized, and poorly reported. Now, a just-released study sponsored by PhRMA, the industry’s trade association, is entitled The Pharmaceutical Supply Chain: […]

Read More
| 1 Comment